“Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.” Reply to a comment by Geddings and Mackman

Carmen Hernandez; Carmen Roncal; Josune Orbe; José A. Páramo

doi:10.1160/TH13-10-0824

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 111(01): 182
DOI: 10.1160/TH13-10-0824

Author Correspondence

Schattauer GmbH

“Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.” Reply to a comment by Geddings and Mackman

Carmen Hernandez

¹Servicio de Hematología, Complejo Hospitalario Universitario de Ourense, Spain

,

Carmen Roncal

²Atherothrombosis Lab, CIMA, University of Navarra, Pamplona, Spain

,

Josune Orbe

²Atherothrombosis Lab, CIMA, University of Navarra, Pamplona, Spain

,

José A. Páramo

²Atherothrombosis Lab, CIMA, University of Navarra, Pamplona, Spain

³Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Spain

› Author Affiliations

Abstract

Full Text

References

References
1 Geddings JE, Mackman N. Comment on “Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients”. Thromb Haemost 2014; 111: 180-181.
2 Hernandez C, Orbe J, Roncal C. et al. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients. Thromb Haemost 2013; 110: 598-608.
3 Combes V, Simon AC, Grau GE. et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
4 Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and micro-particles. Semin Thromb Hemost 2010; 36: 865-875.
5 Gosk-Bierska I, Wysokinski W, Karnicki K. et al. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Int Angiol 2008; 27: 296-301.
6 Kakkar AK, DeRuvo N, Chinswangwatanakul V. et al. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-1005.
7 Sase T, Wada H, Yamaguchi M. et al. Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost 2005; 93: 153-159.
8 Lacroix R, Plawinski L, Robert S. et al. Leukocyteand endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 2012; 97: 1864-1872.
9 Lee RD, Barcel DA, Williams JC. et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 2012; 129: 80-85.